Skip to main content
. 2020 Aug 5;24:100632. doi: 10.1016/j.ymgmr.2020.100632

Table 2.

Biochemical and clinical complications in NBS and no-NBS patients.


Number of patients
Hypoglycemia
High-CK
High-ALT/AST
Metabolic Acidosis
Cardiomyopathy/ Arrhythmia
Myopathy/ Rhabdomyolysis
Neuropathy
Defects No-NBS NBS No-NBS NBS No-NBS NBS No-NBS NBS No-NBS NBS No-NBS NBS No-NBS NBS No-NBS NBS
CUD 2 3 0 0 1 1 0 1 0 0 1 0 1 0 0 0
CPTII 2 0 1 1 0 0 2 0
SCADD 6 0 0 0 0 0 0 0
MCADD 5 2 0 2 1 0 0 0
VLCADD 1 4 0 0 1 2 0 2 0 0 0 0 1 0 0 0
MADD 5 2 0 1 2 1 2 0 1 0 0 0 4 0 0 0
MCADD/MADD 1 2 0 0 1 0 1 0 0 0 0 0 0 0 0 0
VLCADD/LCHADD 1 0 0 0 0 0 0 0

Numbers refer to the number of patients presenting at least once the biochemical and clinical complication reported in columns, at diagnosis (in the case of no-NBS subjects) or during follow up (NBS subjects).